From the Journals

Rare mixed HCV genotypes found in men who have sex with men


 

FROM THE INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

A low percentage of mixed genotypes of hepatitis C virus (HCV) was found in a small study of recently infected HIV+ and HIV– men who have sex with men (MSM) according to a report by Thuy Nguyen, PhD, of the University of North Carolina, Chapel Hill, and colleagues published in the International Journal of Antimicrobial Agents.

SilverV/Thinkstock

The researchers assessed 58 HCV-infected individuals with a median age of 38.5 years, 50 of whom were HIV positive and 18 of whom were HIV negative. Most of the patients were MSM (85.3%), with the rest of unknown sexual orientation. HCV genotyping by Sanger found types GT1a, GT4d, GT3a, and GT2k infection in 47.1%, 41.2%, 8.8%, and 2.9% of the individuals.

After eliminating suspected contaminations, three patients (4.4%) were found with mixed GT infections All three patients were infected with HCV for the first time; two-thirds were coinfected with HIV. The mixed GTs comprised only GT4d and GT1a at different ratios. Mixed infections are potentially problematic when using direct-acting antiviral therapy without broad-spectrum activity, according to the researchers. In this case, however, all HCV patients achieved treatment success.

“From a public health perspective, the MSM population engaging in high-risk behaviors still requires special attention in terms of mixed infections compared with the general HCV-infected population with a regular monitoring of anti-HCV treatment response, particularly when pangenotypic treatment is not used,” the researchers concluded.

The study was funded by the French government; the authors reported having no conflicts.

SOURCE: Nguyen T et al. Int J Antimicrobial Agents. 2019. 54[4]:523-7.

Recommended Reading

Small study suggests natural HCV clearance is caused by AR3-antibody response
MDedge Internal Medicine
Spleen/liver stiffness ratio differentiates HCV, ALD
MDedge Internal Medicine
HCV-infected people who inject drugs also have substantial alcohol use
MDedge Internal Medicine
Statins hamper hepatocellular carcinoma in viral hepatitis patients
MDedge Internal Medicine
HCV coinfection adds to cardiovascular risk in HIV-infected patients
MDedge Internal Medicine
USPSTF issues draft recommendation statement for HCV screening in adults
MDedge Internal Medicine
Some HCV medications associated with serious liver injury
MDedge Internal Medicine
Patients with viral hepatitis are living longer, increasing risk of extrahepatic mortality
MDedge Internal Medicine
Direct-acting antiviral therapy boosts survival for infected HCC patients
MDedge Internal Medicine
HCV+ kidney transplants: Similar outcomes to HCV- regardless of recipient serostatus
MDedge Internal Medicine